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The human endometrium is a highly dynamic tissue with the ability to cyclically 20 
regenerate during the reproductive life. Endometrial mesenchymal stem-like cells 21 
(eMSCs) located throughout the endometrium have shown to functionally contribute 22 
to endometrial regeneration. In this study we examine whether the menstrual cycle 23 
stage and the location in the endometrial bilayer (superficial and basalis portions of 24 
the endometrium) has an effect on stem cell activities of eMSCs (CD140b+CD146+ 25 
cells). Here we show the percentage and clonogenic ability of eMSCs were constant 26 
in the various stages of the menstrual cycle (menstrual, proliferative and secretory). 27 
However, eMSCs from the menstrual endometrium underwent significantly more 28 
round of self-renewal and enabled a greater total cell output than those from the 29 
secretory phase. Significantly more eMSCs were detected in the deeper portion of the 30 
endometrium compared to the superficial layer but their clonogenic and self-renewal 31 
activities remain similar. Our findings suggest that eMSCs are activated in the 32 
menstrual phase for the cyclical regeneration of the endometrium. 33 
 34 
Keywords: Adult stem cells, endometrial repair, menstrual cycle, endometrial stem 35 
cells. 36 




In response to the cyclical changes in ovarian sex steroids, estrogen and progesterone, 39 
the human endometrium displays cyclic and rapid changes in proliferation and 40 
differentiation. The inner mucosal lining of the uterus is composed of the lumen 41 
epithelium supported by stroma and mature glands. The endometrium is comprised of 42 
two layers: the basalis which persists into the next cycle to give rise to a new 43 
functionalis that is shed during menses [1]. Approximately 400 cycles of shedding 44 
and renewing take place during the lifespan of a woman’s reproductive years. The 45 
menstrual cycle is divided into 3 phases: proliferative, secretory and menstrual [2, 3]. 46 
Endometrial regeneration commences at the beginning of menstrual phase and the 47 
growth continues into the proliferative phase. In the estrogen dominating proliferative 48 
phase, 5-7 mm of endometrial tissue is generated within 10 days [3]. The secretory 49 
phase is characterized by glandular secretion and stromal maturation in response to 50 
progesterone from the corpus luteum [4]. In the late secretory phase, luteolysis of the 51 
corupus luteum causes withdrawal of estrogen and progesterone that triggers 52 
breakdown of the functionalis and shedding of a substantial amount of tissue [5].  53 
In recent years, a distinct adult stem cell population known as endometrial 54 
mesenchymal stem-like cells (eMSCs) have been shown to be responsible for 55 
endometrial remodeling [6]. Endometrial stromal cells co-expressing two surface 56 
markers: CD140b and CD146 are enriched with eMSCs and are localized to 57 
perivascular regions in the functionalis and basalis layers [7]. These cells are 58 
clonogenic, have broad differentiation capacity, display properties and phenotype 59 
similar to other mesenchymal stem cells [8-10]. Although eMSCs share a core genetic 60 
profile with bone-marrow mesenchymal stem cells in stemness, several genes mainly 61 
related to endometrial functions such as, vasculogenesis, angiogenesis, inflammation, 62 
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immunomodulation and cell communication are specifically upregulated in eMSCs 63 
[11].  64 
EMSC expressing CD140b and CD146 have been identified in proliferative and 65 
secretory endometria and can be isolated from hysterectomy or endometrial biopsy 66 
tissues [7, 8, 11]. However, the characterization of eMSCs at menstruation is limited 67 
and no studies have compared the properties of eMSCs in the different layers of the 68 
endometrium (superficial vs. deep portion of the endometrium). We hypothesize that 69 
1) more eMSCs reside in the basalis but their stem cells activities will be similar 70 
between the endometrial layers. 2) These eMSCs will exhibit unique properties at 71 
menstruation for the repair and regeneration of the endometrium. Therefore, this study 72 
aims to investigate the changes of eMSCs during the menstrual phases (proliferative, 73 
secretory and menstrual) and in the endometrial layers.  74 
MATERIAL AND METHODS 75 
Human tissues  76 
Full thickness endometrial tissue was collected from 30 ovulating women, 35- to 50- 77 
years old undergoing total abdominal hysterectomy (TAH) for benign non-78 
endometrial pathologies (supplementary data TableS1). They had not taken hormonal 79 
therapy for three months before surgery. The phase of the menstrual cycle was 80 
categorized into proliferative (n = 14; range: 40 to 48 years old; median: 45yr; mean: 81 
44 yr) and secretory (n = 16, range: 35 to 50 years old; median: 44yr; mean: 42 yr) by 82 
experienced histopathologists based on hematoxylin-eosin-stained endometrial 83 
sections. Menstrual endometrial tissues were obtained from 11 ovulating women aged 84 
from 31- to 40- years old attending the infertility clinic on day 2-3 of their menstrual 85 
cycle (median: 38yr; mean: 36 yr, supplementary data TableS2). Ethic approval was 86 
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obtained from the Institutional Review Board of the University of Hong 87 
Kong/Hospital Authority Hong Kong West Cluster. Written consents were signed by 88 
recruited subjects after detailed counseling prior to participation of the study. All the 89 
samples were processed within 24 hours after collection. 90 
 91 
Single cell suspensions of endometrial epithelial and stromal cells 92 
For TAH samples (Fig 1A), the endometrial layer was scraped off from the 93 
underlying myometrium, minced and digested with PBS containing collagenase type 94 
III (0.3 mg/ml, Worthington Biochemical Corporation, Freehold, NJ, USA) and 95 
deoxyribonuclease type I (40 µg/ml, Worthington Biochemical Corporation) for one 96 
hour at 37oC, as described previously [12]. To separate the superficial layer, a gentle 97 
scrape on top of the endometrial layer most distal from the myometrium was 98 
performed. The deeper portion of the endometrium was defined as the remnant tissue 99 
1mm-area from the endo-myometrial junction (Fig 1B) [13]. Menstrual samples were 100 
obtained on day 2 of the menstrual cycle by aspiration. They were digested as 101 
described above. In brief, red blood cells were removed using Ficoll-Paque (GE 102 
Healthcare, Uppsala, Sweden) density-gradient centrifugation. Leukocytes were 103 
eliminated using anti-CD45 antibody-coated Dynabeads (Invitrogen, Waltham, MA, 104 
USA). Epithelial cells were removed from the stromal cells by using anti-CD326 105 
(EpCAM) antibody-coated microbeads (Miltenyi Biotec Inc., San Diego, CA, USA). 106 
The freshly purified stromal cells (6000 – 8000 cells/cm2) were plated onto 100 mm 107 
dishes (BD Biosciences, San Jose, CA, USA) coated with fibronectin (1 mg/ml, 108 
Invitrogen) and cultured in growth medium  containing 10% FBS (Invitrogen), 1% 109 
antibiotics (Invitrogen) and 1% L-glutamine (Invitrogen) in DMEM/F-12 (Sigma-110 
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Aldrich, St Louis, MA, USA). Stromal cells were expand in culture for 7-14 days in a 111 
humidified carbon dioxide incubator at 37oC. Medium was changed every 7 days until 112 
it reach 80% confluence. 113 
 114 
Flow cytometry 115 
The expression of eMSC markers (co-expression of CD140b and CD146) on freshly 116 
purified endometrial cells were analyzed using multicolour flow cytometry 117 
(Supplementary data Figure S1).  Endometrial cells were labeled with phycoerythrin 118 
(PE)-conjugated antibody against platelet-derived growth factor receptor beta 119 
(PDGFRβ) (CD140b, 2.5 µg/ml, PR7212 clone, mouse IgG1, R&D Systems, 120 
Minneapolis, MN, USA) and fluorescein isothiocyanate (FITC)-conjugated anti-121 
CD146 antibody (1 mg/ml, OJ79c clone, mouse IgG1, Thermo Fisher Scientific, 122 
Waltham, MA, USA) or isotype matched controls. The cells were then labeled with 123 
allophycocyanin (APC)-conjugated anti-CD45 antibody (10 µg/ml, Thermo Fisher 124 
Scientific) before resuspension in 0.1% BSA/PBS for flow cytometric analysis using 125 
BD Fortressa (BD Biosciences, San Jose, CA, USA) in the University of Hong Kong 126 
Faculty Core Facility. Flow cytometry data were analyzed using the FlowJo software 127 
(Tree Star, Ashland, OR, USA). 128 
 129 
Magnetic bead selection for endometrial mesenchymal stem-like cells 130 
EMSCs isolated by sequential beading with magnetic beads coated with anti-CD140b 131 
and anti-CD146 antibodies were used for various functional assessments. In brief, 132 
cultured stromal cells were trypsinized, re-suspended in 0.5% BSA/PBS and 133 
incubated with PE-conjugated anti-CD140b antibody (10 µl/106 cells) for 45 min at 134 
4oC. The cells were then incubated with anti-mouse IgG1 coated microbeads 135 
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(Miltenyi Biotec Inc.) for 15 min at 4oC and the cell suspensions were applied to 136 
Miltenyi MS columns with a magnetic field to collect the CD140b+ cells. The stromal 137 
CD140b+ population were seeded in fibronectin-coated 100-mm culture dishes (BD 138 
Biosciences) containing growth medium and cultured at 37oC in 5% CO2 for 7 to 10 139 
days to allow detachment of the microbeads during cell expansion. The CD140b+ 140 
cells were then trypsinized and incubated with anti-CD146 antibody coated 141 
microbeads (Miltenyi Biotec Inc.) for 15 min at 4oC. The CD140b+CD146+ cells 142 
(eMSCs) were obtained after column separation and the phenotype was confirmed by 143 
dual immunofluorescence (Supplementary data Fig S2).    144 
Dual Immunofluorescence 145 
Double immunofluorescent staining was performed to evaluate the phenotypic of 146 
CD140b+CD146+ cells. Some of the eMSCs were plated at clonal density of 10-30 147 
cells/cm2 on fibronectin coated 12-well plates and culture for 15 days. Cells were 148 
fixed with 4% paraformaldehyde for 20 min. Permeabilization was performed using 149 
0.1% Triton-X 100 for 10 min and blocked with 2% BSA for 30 min. Cells were 150 
incubated with primary antibodies; anti-human CD140b (R&D Systems) and anti-151 
human CD146 (Abcam, Cambridge, UK) antibodies at 4oC overnight. The following 152 
day, cells were incubated with the secondary antibodies; donkey anti-mouse 153 
antibodies conjugated with Alexa Fluor 564 (Invitrogen) and goat anti-rabbit 154 
antibodies conjugated with Alexa Fluor 488 (Invitrogen). The cell nuclei were 155 
detected by DAPI (Thermo Scientific). All washing steps were performed with PBS 156 
and conducted at room temperature unless specified. Images were captured using a 157 
Carl Zeiss LSM inverted confocal microscope and a Zeiss LSM Zen 2010 software 158 
(Carl Zeiss, Munich, Germany) at the University Of Hong Kong Core Facility.  159 
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Colony initiating cell assay 160 
For assessment of colony-forming ability, eMSCs were plated in triplicates at a clonal 161 
density of 10-30 cells/cm2 on fibronectin coated 100 mm dishes or 6-well plates and 162 
cultured for 15 days as previously described [14]. Cells were cultured in growth 163 
medium, incubated at 37oC in 5% CO2 and medium changed every seven days. 164 
Regular monitoring of the cells was performed under an inverted microscope (Nikon) 165 
to ensure colonies derived from single cells. Colony forming units (CFUs) were 166 
stained with toluidine blue (Sigma-Aldrich) on day 15. Large CFUs were defined as 167 
colonies with ≥4,000 cells and small CFUs were those with 4,000 cells. The colony 168 
forming ability was determined by the number of CFUs formed divided by the 169 
number of cells seeded, multiplied by 100. 170 
 171 
In vitro serial cloning 172 
Individual large stromal CFUs from passage 1 (P1) were trypsinized using cloning 173 
rings (Sigma-Aldrich) to determine the self-renewal capacity of the cells in different 174 
stages of the menstrual cycle. Two individual large CFUs per patient samples 175 
obtained from the clonogenic assays were used for serial cloning. The cell number of 176 
each CFUs was determined and the cells were re-seeded at a density of 35 cells/cm2 177 
[14]. The process continued until the cells could no longer form CFUs. Similar 178 
procedure was carried out for the difference between large and small CFUs.   179 
 180 
Total cell output assay 181 
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The proliferative potential of CFUs derived eMSC in different menstrual phases was 182 
examined by separately pooling 6 large CFUs, and expanding them in culture with a 183 
seeding density of 2,000 cells/cm2 [14]. The growth of the cells was closely 184 
monitored and passaged every 4 to 7 days when the culture was 80% confluent. The 185 
process continued until senescence of the cells. The cumulative population is the sum 186 
of output cell number at each passage. 187 
 188 
Statistical analysis 189 
Data were analyzed using GraphPad PRISM software (version 5.00; GraphPad 190 
Software Inc., San Diego, CA, USA). Distribution normality was examined using the 191 
D’Agostino and Pearson test. Mann-Whitney test was performed to determine 192 
statistical significance between two groups. For comparing three groups, the data 193 
were analyzed using Kruskal-Wallis test, follow by Dunn’s post-test. Wilcoxon 194 
matched pairs test was performed to compare proportion of eMSCs in the superficial 195 
and deep portion of the endometrium. Data are presented as mean ± SEM. Results 196 
were considered statistically significant when P < 0.05.  197 
 198 
RESULTS 199 
Proportion of CD140b+CD146+ cells in different menstrual phases and endometrial 200 
layers  201 
The expression for the eMSC markers (CD140b+CD146+ cells) in freshly isolated 202 
endometrial cells was analyzed by flow cytometry to determine the percentage of 203 
eMSCs in the total endometrial population. The proportion of eMSCs was similar 204 
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among the three phases of the menstrual cycle (Fig 2A). The percentage of cells co-205 
expressing CD140b+CD146+ cells in the menstrual phase was 3.83 ± 1.31% (n = 7), in 206 
the proliferative phase was 1.60 ± 0.52% (n = 10) and in the secretory phase 207 
endometrium was 2.41 ± 1.71% (n = 6).  208 
Assessment of eMSCs in different endometrial layers by flow cytometry showed a 209 
significantly higher percentage of CD140b+CD146+ cells in the deep portion of the 210 
endometrium than in the superficial layer (n = 4, P < 0.05, Fig 2B). 211 
We also examine the expression of CD140b+CD146+ cells in large and small CFUs by 212 
dual immunofluorescence. In general, more co-expressing cells were detected within 213 
large CFUs compare to small CFUs (supplementary data S3A, S3B). 214 
   215 
The clonogenic and self-renewal activity of eMSCs in different menstrual phases 216 
and endometrial layers 217 
To examine the effect of menstrual cycling on the clonogenic activity of eMSCs, 218 
cloning efficiencies were compared among samples obtained in the menstrual, 219 
proliferative and secretory phases using magnetic bead selection. The cloning 220 
efficiencies were determined from the number of large and small CFUs relative to the 221 
total number of seeded cells. Fig 3A shows the clonogenic activity of eMSCs in the 222 
menstrual phase that formed large CFUs (0.79 ± 0.35%, n = 9) was similar to that in 223 
the proliferative phase (0.60 ± 0.21%, n = 9) and the secretory phase (0.44 ± 0.15%, n 224 
= 12). There was also no difference in the cloning efficiencies for small CFUs 225 
(menstruating, 3.62 ± 1.50%, n = 9; proliferative, 2.25 ± 0.90%, n = 9; secretory, 4.02 226 
± 0.86%, n = 12) (Fig 3B).   227 
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The self-renewal ability of large CFUs in different menstrual phases was assessed 228 
using a serial cloning strategy (Fig 3C). Clonally derived eMSCs in menstruating 229 
endometrium underwent significantly more rounds of self-renewal (5.25 ± 0.48, n = 4) 230 
than those in the secretory phase (3.33 ± 0.24, n = 9, P <0.05) but not those in 231 
proliferative phase (3.75 ± 0.25, n = 4, P = 0.06).  232 
Large CFUs from eMSCs in the menstrual phase samples were able to serially clone ≥ 233 
5 rounds, where 0.21% of eMSCs were able to initiate CFUs in the second round, 234 
0.80% of in the third round, 0.23% in the fourth and 0.015% in the fifth round (Fig 235 
3D). For the proliferative phase samples, some of the large CFUs could passage ≥ 3 236 
rounds, where 0.45% of the cells could initiate CFUs in the second round and 0.75% 237 
in the third round. Similarly, some of the large CFUs in secretory phase could passage 238 
≥ 4 rounds, where 0.26% of the cells initiated CFUs in the second round, 0.01% in the 239 
third round and 0.75% in the fourth round. 240 
The percentage of eMSCs that formed large CFUs was 0.63 ± 0.28% (n = 5) in the 241 
superficial layer and 2.28 ± 1.02% (n = 5, Fig 3E, P = 0.25) in the deep portion of the 242 
endometrium. There was no statistical difference in the formation of small CFUs in 243 
superficial (3.51 ± 1.54%) and deep (3.02 ± 1.70%, Fig 3F) layers. The self-renewal 244 
activity of large CFUs was similar between the superficial (3.20 ± 0.58%, n = 5) and 245 
the deep layer of the endometrium (2.60 ± 0.40%, n = 5, Fig 3G).  246 
In general, eMSCs that formed large CFUs could under more rounds of self-renewal 247 
(3.67 ± 0.67, n = 3) than small CFUs (0.33 ± 0.33, n=3) although this was not 248 
statistically different (supplementary data S3E, P = 0.07).   249 
 250 
Proliferative potential of eMSCs in different menstrual phases 251 
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The proliferative potential was determined by serial passaging clonally derived 252 
eMSCs until senescence (Fig 4A). The eMSCs from the menstrual phase (6.41 ± 3.82 253 
x 1011, n = 5) and the proliferative phase (2.02 ± 1.75 x 1011, n = 6) produced larger 254 
cumulative cell number than those from the secretory phase (1.10 ± 0.61 x 109, n = 4, 255 
P < 0.05). The number of cells yielded at each passage is shown in Fig 4B. The total 256 
time required for the large CFUs to reach senescence was 106.40 ± 10.29 days for the 257 
menstruation phase, 90.17 ± 7.82 days for proliferative phase and 84.25 ± 5.23 days 258 
for the secretory phase. 259 
 260 
DISCUSSION 261 
In this study, we identified and characterized the putative population of endometrial 262 
stromal stem/progenitor cells in three phases of the menstrual cycle and in superficial 263 
and deep portions of the human endometrium. We showed that the percentage and 264 
clonogenicity of eMSCs (CD140b+CD146+ cells) were relatively consistent across the 265 
menstrual cycle. An intriguing finding from this study was that eMSCs in the 266 
menstrual phase exhibited the greatest self-renewal ability and yielded a higher output 267 
of cells. These findings support the notion that endometrial stem cells are responsible 268 
for the repair of the endometrium after menstruation. We also showed that more 269 
eMSCs resided in the deep endometrial portion but their stem cell properties were 270 
similar across the endometrial layers. Hence, eMSCs can readily be obtained from 271 
both layers of the endometrium. 272 
Endometrial regeneration starts at menstruation [15, 16]. Therefore, it is logical that 273 
the niche at this stage should activate stem cells for endometrial repair. Consistently, 274 
our data showed that eMSCs obtained during menstruation exhibit better proliferative 275 
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and self-renewal activity than secretory phase. This was not surprising, since in the 276 
secretory phase the growth of the endometrium has ceased and decidualization begins 277 
[3, 17]. Also, endometrial regeneration continues into the proliferative phase [18], 278 
therefore the eMSCs from menstruation and proliferative samples were similar. In 279 
adults, homeostasis between the quiescent and activated states of stem cells are 280 
important to protect stem cells from losing their potential to self-renewal whilst 281 
support ongoing tissue regeneration. The observed phenomenon displayed by eMSCs 282 
at menstruation indicates the resident stem cells are responsive to local and systemic 283 
signals provided by the niche cells during the tissue breakdown. Although 284 
menstruation endometrium displayed a higher percentage of eMSCs, it was not 285 
statistically significant. In this study, two methods were used for the collection of 286 
endometrial samples. Endometrial aspirations correspond to the superficial parts of 287 
the breakdown tissue and hysterectomy samples are full thickness endometrium. Due 288 
to the limitation in obtaining hysterectomy samples during menstruation, our current 289 
data do not represent the percentage of eMSCs from deep portion of the endometrium.  290 
In addition, more active eMSCs detected from menstruation endometrium may be due 291 
to the age differences between the sample groups.     292 
Published report examining samples from proliferative and secretory phase 293 
demonstrated eMSCs comprises 1.5% of endometrial stromal cells, similar to our 294 
current finding [8]. Large CFUs from menstrual phase eMSCs and stromal cells can 295 
passage up to five times and display similar proliferative potentials [19]. In this study, 296 
a lower clonogenic activity was observed this is likely to be related to the different 297 
technical methods used for isolating eMSCs [8].  298 
The endometrium is functionally comprised of a polarized gradient of cells with 299 
different phenotypes. The functionalis undergo a striking progression of histological 300 
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changes in the menstrual cycle, while the basalis remains relatively unchanged. The 301 
existence of putative stem cells in the lower endometrial layer has been well-302 
documented [17, 20, 21]. Here we also found the relative percentage of eMSCs 303 
residing in the deeper portion of the endometrium was higher than the superficial 304 
layer. Although eMSCs are well distributed throughout the endometrium, no 305 
comparative study has been conducted between the endometrial layers [7, 8, 11]. In 306 
this study, we demonstrated that the clonogenic activity and self-renewal 307 
characteristic of eMSCs in both endometrial layers were similar. These findings 308 
support the stem cell theory that eMSCs shed during menstruation may contribute to 309 
the pathogenesis of endometriosis [6, 22]. Although the superficial layer contains 310 
relatively lower numbers of eMSCs, it has been proposed that endometriotic lesions 311 
initiated by endometrial stem/progenitor cells would be more severe than lesions 312 
initiated by more differentiated cells [23]. Several functional studies support the 313 
presence of endometrial stem cells in ectopic endometriotic lesions [24-26].  A recent 314 
gene expression profiling study provided new important information on the molecular 315 
phenotype and relationship between eMSCs vs. its progeny stromal fibroblast and 316 
their respective roles in endometriosis [27]. The authors demonstrate the differential 317 
expression of eMSC lineage genes from normal and endometriotic samples. In 318 
addition, eMSCs from women with endometriosis exhibit progesterone resistant and 319 
endometrial stromal fibroblast inherit this inability to decidualize in vitro. These 320 
findings indicate gynecological disorder such as endometriosis can affect eMSCs.    321 
Given that the unique microenvironment at menstruation can active eMSCs, a better 322 
understanding between the communications of niche cells to stem/progenitor cells is 323 
necessary for future cell-based therapies in tissue engineering applications. This study 324 
also confirms that a higher eMSC subpopulation reside in the deeper portion of the 325 
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endometrium. Studies understanding how eMSCs respond to shifting physiological 326 
cues during the menstrual cycle are needed. In addition, the molecular events 327 
governing the transition between quiescence and activation of eMSCs remain to be 328 
explored.  329 
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FIGURE LEGEND  341 
Figure 1 – Hematoxylin and eosin staining of the human endometrium. (A) Full 342 
thickness of human endometrium. (B) Depth of the scrape showing the remnant deep 343 
endometrial portion after separation from the superficial layer. Superficial layer, deep 344 
portion of the endometrium and myometrium are separated by dotted lines. The upper 345 
superficial layer contains multiple glands supported by loose stroma, while the lower 346 
portion consists of branched glands with dense stroma. Scale bar: 100 µM. 347 
16 
 
Figure 2 – Proportion of eMSCs during the menstrual cycle and in different 348 
layers of the endometrium. (A) Percentage of CD140b+CD146+ cells in 349 
menstruation, proliferation and secretory endometrium. (B) The relative percentage of 350 
CD140b+CD146+ cells in the superficial compared to the deep portion of 351 
endometrium. Results shown as mean ± SEM. * P < 0.05. Numbers in parentheses 352 
indicate sample size. EMSCs, endometrial mesenchymal stem-like cells; SEM, 353 
standard error of the mean. 354 
Figure 3 – The clonogenic and self-renewal activity of eMSCs in different cycle 355 
stage and endometrial layers. Cloning efficiency of human eMSCs from 356 
menstruation, proliferative and secretory endometrium for (A) large and (B) small 357 
CFUs. (C) Number of serially cloned passages of the large CFUs at different 358 
menstrual stage. (D) Percentage of large CFUs at each passage of serial cloning. The 359 
clonogenicity of human eMSCs from superficial and deep portion of the endometrium 360 
for (E) large and (F) small CFUs. (G) Number of serial passage for large CFUs in 361 
different endometrial layers. Results shown as mean ± SEM. * P < 0.05. Numbers in 362 
parentheses indicate sample size. CFUs, colony-forming units; eMSCs, endometrial 363 
mesenchymal stem-like cells; SEM, standard error of the mean. 364 
Figure 4 – Long-term Proliferative potential of eMSCs in different menstrual 365 
stage. (A) The total cumulative output of eMSCs in different menstrual stage. (B) 366 
Growth curve of eMSCs in menstrual (circle), proliferative (square) and secretory 367 
(triangle) phase. Each point represents the cell yield obtained at each passage. Results 368 
shown as mean ± SEM. * P < 0.05. Numbers in parentheses indicate sample size. 369 
EMSCs, endometrial mesenchymal stem-like cells; SEM, standard error of the mean. 370 
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Supplementary Figure S1 – Gating strategy for co-expression of CD140b and 371 
CD146 in human endometrial cells. (A) Freshly isolated human endometrial cells 372 
were analyzed by flow cytometry for expression of cell surface markers. Viable cells 373 
were selected by their forward scatter (FSC) and side scatter (SSC) profile. (B) Cell 374 
properties; SSC area (SSC-A) versus SSC height (SSC-H) to gate out cell doublets 375 
and aggregates to ensure the signal arises from single cell. Leukocytes were removed 376 
by electronic gating using CD45-APC. Single parameter histograms for individual 377 
markers CD146-FITC, CD140b-PE. (C) Grey line indicates background fluorescence 378 
with isotype matched IgG control. Percentage of CD140b+CD146+ cells from (D) 379 
superficial portion, (E) deep portion and (F) full thickness endometrium. 380 
Representative dot-plots for co-staining of CD140b and CD146.  381 
Supplementary Figure S2 – Immunofluorescent staining of CD140b and CD146 382 
on endometrial stromal cells after microbeads isolation. (A) The surface marker 383 
CD140b (red) on endometrial stromal cells was confirmed by immunofluorescence 384 
after CD140b+ microbeads selection. (B) All cells co-expressed CD140b (red) and 385 
CD146 (green) after the second CD146+ microbeads isolation. DAPI nuclear stain 386 
(blue). Scale bar: 100 µM. 387 
Supplementary Figure S3 – Phenotypic Expression and Serial Activity of large 388 
and small eMSC CFUs. Representative images showing the co-expression of 389 
CD140b (red) and CD146 (green) cells on (A) large and (B) small CFUs. DAPI 390 
nuclear stain (blue). Images showing the negative control of (C) mouse IgG and (D) 391 
rabbit IgG. (E) Number of passage from large and small CFUs (n=3). Results shown 392 
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Supplementary Table S1 - Pathological Characteristic of Full Thickness Endometrial Samples 
 Age Menstrual Phase Pathology 
1 47 proliferative leiomyomas 
2 47 proliferative leiomyomas 
3 45 proliferative leiomyomas 
4 44 proliferative leiomyomas 
5 41 proliferative adenomyosis 
6 41 proliferative adenomyosis +  leiomyomas 
7 40 proliferative leiomyomas 
8 48 proliferative leiomyomas 
9 43 proliferative leiomyomas 
10 47 proliferative adenomyosis 
11 47 proliferative leiomyomas 
12 45 proliferative adenomyosis +  leiomyomas 
13 48 proliferative leiomyomas 
14 41 proliferative leiomyomas 
15 44 secretory leiomyomas 
16 50 secretory leiomyomas 
17 48 secretory adenomyosis  
18 44 secretory leiomyomas 
19 43 secretory leiomyomas 
20 45 secretory leiomyomas 
21 42 secretory leiomyomas 
22 40 secretory leiomyomas 
23 48 secretory adenomyosis +  leiomyomas 
24 48 secretory leiomyomas 
25 46 secretory leiomyomas 
26 40 secretory leiomyomas 
27 36 secretory leiomyomas 
28 35 secretory leiomyomas 
29 36 secretory leiomyomas 
30 37 secretory leiomyomas 
 
  
Supplementary Table S2 – Age of Menstruation Samples 
 Age Menstrual Phase 
1 39 Menstrual 
2 31 Menstrual 
3 40 Menstrual 
4 40 Menstrual 
5 38 Menstrual 
6 38 Menstrual 
7 37 Menstrual 
8 32 Menstrual 
9 34 Menstrual 
10 39 Menstrual 
11 33 Menstrual 
 
